Emily Schlosnagle

Prevalence of germline variants in inflammatory breast cancer

J. Garber, M. Regan, B. Overmoyer, 2019, Cancer.

Metabolic Characterization of Inflammatory Breast Cancer With Baseline FDG‐PET/CT: Relationship With Pathologic Response After Neoadjuvant Chemotherapy, Receptor Status, and Tumor Grade

Su-Chun Cheng, J. Bellon, B. Overmoyer, 2019, Clinical breast cancer.

Discrepancy between FDG-PET/CT and contrast-enhanced CT in the staging of patients with inflammatory breast cancer: implications for treatment planning

Su-Chun Cheng, J. Bellon, B. Overmoyer, 2020, Breast Cancer Research and Treatment.